Pfizer acquired the Eucrisa (crisaborole) when it bought its developer, Anacor in May this year for $5.2 billion. Skip to main content Tuesday 24 December 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback